Save your seat for our first ever night shift webinar! Tuesday, July 16th at 10:00 pm EST Join three of the Principal Investigators of HYPERACT, the 2024 Society of Critical Care Medicine Star Research Award Winner, which determined High Velocity Therapy as a reasonable alternative to NiPPV for moderate - severely hypercapnic, COPD patients (for spontaneously breathing patients only). See you there! #HYPERACT #Vapotherm #LiveWebinar #FreeCEU
Vapotherm’s Post
More Relevant Posts
-
Our #CHEST2023 abstract unveils groundbreaking insights from our device feasibility study, where we harnessed the power of our RESP Biosensor to explore the link between respiratory sounds and pulmonary health in a patient with COPD. Our findings suggest that monitoring the increasing frequency of abnormal lung sounds in the post-acute phase can predict clinical deterioration, offering hope for more effective COPD management and early intervention. The study also highlights the value of outpatient data as a baseline for assessing early worsening and the stability of abnormal respiratory sounds over time as an independent biomarker for guiding clinical decisions, irrespective of vital signs or oxygen requirements. Read the abstract for study details: https://lnkd.in/eN8kKqU5
To view or add a comment, sign in
-
-
It's #PRWeek2024 and the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) is spotlighting the crucial role of pulmonary rehabilitation in improving the lives of those with lung disease. Pulmonary Rehabilitation (PR) is a highly effective therapy for Chronic Obstructive Pulmonary Disease (COPD), improving symptoms, exercise capacity and quality of life. Sadly, less than 3% globally currently have access to pulmonary rehabilitation (https://lnkd.in/eadYgVst). In the US, challenges persist, with just 1 traditional PR centre for every 6,030 COPD patients (https://lnkd.in/eZxPw3rD) But we've got the solution- myCOPD! Our digitally enhanced pulmonary rehab model is revolutionizing the landscape and increasing access to PR. Together, let's ensure PR is accessible to all who need it. Join our journey and be a part of the change. Get in touch today to find out more about myCOPD. https://lnkd.in/gTnuuHrQ #PulmonaryRehabilitation #HealthcareAccessibility #Innovation #HealthTech
To view or add a comment, sign in
-
-
Watch Dr Whittles lecture. Maskless NIV is equivalent at CO2 reduction when compared to mask NIV and clearly superior in patient comfort to mask NIV. The data speaks for itself.
Discover how high velocity therapy could be a game-changer for COPD patients. Watch as Dr Jessica Whittle presents the #HYPERACT study findings detailing how this innovative approach might reduce the need for invasive ventilation methods in those patients with moderate to severe COPD. https://hubs.ly/Q02qWjfB0
To view or add a comment, sign in
-
In the latest Medscape clinician handbook and CME activity, learn how to identify potential candidates for endobronchial valve treatment and how it can improve quality of life for severe COPD/emphysema patients. https://bit.ly/3THFGp3 #Medscape #BLVR #Pulmonology
To view or add a comment, sign in
-
-
Patient Compliance: Discover Our Latest White Paper Today! 📣 📚🏥 This white paper provides an overview of pharmacological compliance and outcomes in cardiac and pulmonary conditions. Inside, we look at treatment options for Atrial Fibrillation and COPD, as well as difficulties in AF/COPD treatment compliance. Download now through the link in the comments! #PatientCompliance #Innovation #COPD #AtrialFibrillation
To view or add a comment, sign in
-
-
Patient Compliance: Download Our NEW White Paper Now! 📣 📚🏥 This white paper provides an overview of pharmacological compliance and outcomes in cardiac and pulmonary conditions. Inside, we look at treatment options for Atrial Fibrillation and COPD, as well as difficulties in AF/COPD treatment compliance. Download now through the link in the comments! #PatientCompliance #Innovation #COPD #AtrialFibrillation
To view or add a comment, sign in
-
-
At #CHEST2023, pulmonary experts will be presenting GSK’s program, “Optimizing Health Care Delivery in COPD.” This discussion will address the positive impacts of switching from dual therapy to single-inhaler triple therapy for #COPD patients. Learn more about triple therapy: https://gsk.to/3QaNeis
To view or add a comment, sign in
-
#ICYMI - Dr. David Hatfield, our Chief Physician Executive, shares how our care teams can help our patients figure out which medications, devices and lifestyle changes are right for them when managing #COPD. In partnership with the COPD Foundation, our goal is to raise awareness around this disease, identify��those with undiagnosed COPD, and increase access to pulmonary rehabilitation. Watch the full webinar and learn more at https://lnkd.in/dmSnaPHq
To view or add a comment, sign in
-
Research shows that pulmonary rehabilitation helps people with COPD stay healthier and reduces hospitalizations and that home-based programs can be as effective as center-based programs. Learn how to support your patients on their healthcare journey. #standardofcare #respiratorytherapy #remotecare #lunghealth
Virtual Pulmonary Rehabilitation | Benefits
https://morlenhealth.com
To view or add a comment, sign in
-
PFT Machine Working Video 🧑💻 🫁PFT (Pulmonary Function Testing) machine is a🏥 medical device used to assess lung function. It measures parameters like lung capacity, airflow, and how well the🫁 lungs exchange gases. 🏥PFTs are crucial for diagnosing and managing respiratory conditions such as asthma, chronic obstructive pulmonary disease🫁 (COPD), and lung fibrosis.LIG HEALTHCARE #hospital #traning #biomedicalengineering
To view or add a comment, sign in